JAK3 and acute lymphoblastic leukemia: SUZ12 LOF mutations have also been associated with JAK3 in T-ALL with an ablation of SUZ12 co-operating with JAK3 M511I to drive transformation in a mouse pro-T cell ex vivo model [64].